Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 Study

Telavancin is a bactericidal lipoglycopeptide with a multifunctional mechanism of action. We conducted a randomized, double blind, active-control phase II trial. Patients ≥18 years of age with complicated skin and skin structure infections caused by suspected or confirmed gram-positive organisms wer...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Stryjewski, Martin E., Chu, Vivian H., O'Riordan, William D., Warren, Brian L., Dunbar, Lala M., Young, David M., Vallée, Marc, Fowler, Vance G., Morganroth, Joel, Barriere, Steven L., Kitt, Michael M., Corey, G. Ralph
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2006
Matèries:
Clinical Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1426424/
https://ncbi.nlm.nih.gov/pubmed/16495243
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.50.3.862-867.2006
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars